FDA wants MRI contrast agent warning

May 23, 2007

The U.S. Food and Drug Administration wants a warning printed on the labels of all gadolinium-based magnetic resonance imaging contrast agents.

The requested boxed warning would state patients with severe kidney insufficiency who receive the chemicals used to enhance the quality of MRI images are at risk of developing a debilitating and a potentially fatal disease known as nephrogenic systemic fibrosis, or NSF.

In addition, the FDA wants the warning to state that patients just before or just after liver transplantation, or those with chronic liver disease, are also at risk.

Gadolinium-based contrast agents are commonly used to improve the visibility of internal structures when patients undergo an MRI. Reports have identified the development of NSF following single and multiple administrations of the gadolinium-based contrast agents.

Copyright 2007 by United Press International

Explore further: Indian yoga guru B.K.S. Iyengar dies at 95

add to favorites email to friend print save as pdf

Related Stories

Luxembourg shows 'bigger is not always better'

Apr 19, 2013

Sometimes good things come in small packages and this is indeed true of Luxembourg when it comes to information and communication technologies (ICT). Take the example of broadband rollout. Being a small country ...

Romper suit to protect against SIDS

Jan 31, 2013

Parents of newborn babies are always creeping into the nursery at night to check that their infant is still breathing. Alternatively, they might let the baby sleep in their room, hoping to notice any respiratory ...

Romper suit to protect against sudden infant death

Jan 07, 2013

Breathing sensors built into romper suits could help prevent sudden cot deaths in the future. The basis for this is a stretchable printed circuit board that fits to the contours of the body and can be manufactured ...

Recommended for you

User comments : 0